KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,855,954 | -28.1% | 11,086,533 | -3.9% | 0.00% | -100.0% |
| Q2 2023 | $20,651,735 | -41.5% | 11,537,281 | +27.2% | 0.00% | 0.0% |
| Q1 2023 | $35,290,810 | +22.0% | 9,072,188 | +6.6% | 0.00% | 0.0% |
| Q4 2022 | $28,928,007 | -33.0% | 8,508,237 | +7.5% | 0.00% | 0.0% |
| Q3 2022 | $43,203,000 | +17.9% | 7,912,954 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $36,635,000 | -37.3% | 8,122,849 | +2.5% | 0.00% | -50.0% |
| Q1 2022 | $58,427,000 | +1.9% | 7,927,618 | -11.1% | 0.00% | +100.0% |
| Q4 2021 | $57,343,000 | +12.1% | 8,918,206 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $51,160,000 | -43.5% | 8,790,318 | +0.1% | 0.00% | -66.7% |
| Q2 2021 | $90,621,000 | +11.2% | 8,781,248 | +13.3% | 0.00% | +50.0% |
| Q1 2021 | $81,528,000 | -29.5% | 7,749,757 | +3.7% | 0.00% | -50.0% |
| Q4 2020 | $115,713,000 | +10.5% | 7,475,099 | +4.3% | 0.00% | 0.0% |
| Q3 2020 | $104,679,000 | -13.5% | 7,169,789 | +12.2% | 0.00% | -20.0% |
| Q2 2020 | $121,002,000 | +18.3% | 6,388,662 | +20.0% | 0.01% | 0.0% |
| Q1 2020 | $102,313,000 | +11.9% | 5,326,002 | +11.7% | 0.01% | +25.0% |
| Q4 2019 | $91,419,000 | +102.3% | 4,768,926 | +1.5% | 0.00% | +100.0% |
| Q3 2019 | $45,190,000 | +66.7% | 4,697,537 | +3.8% | 0.00% | +100.0% |
| Q2 2019 | $27,112,000 | +11.1% | 4,526,508 | +8.3% | 0.00% | 0.0% |
| Q1 2019 | $24,404,000 | -38.8% | 4,178,808 | -1.9% | 0.00% | -50.0% |
| Q4 2018 | $39,896,000 | -45.0% | 4,257,912 | -0.1% | 0.00% | -33.3% |
| Q3 2018 | $72,556,000 | +5.3% | 4,260,531 | +5.1% | 0.00% | 0.0% |
| Q2 2018 | $68,905,000 | +86.2% | 4,055,634 | +47.0% | 0.00% | +50.0% |
| Q1 2018 | $37,014,000 | +46.1% | 2,758,063 | +4.5% | 0.00% | +100.0% |
| Q4 2017 | $25,335,000 | -24.2% | 2,639,151 | -13.3% | 0.00% | -50.0% |
| Q3 2017 | $33,411,000 | +24.7% | 3,042,867 | +2.8% | 0.00% | +100.0% |
| Q2 2017 | $26,788,000 | -16.8% | 2,959,957 | +18.1% | 0.00% | -50.0% |
| Q1 2017 | $32,192,000 | +82443.6% | 2,507,207 | +60227.4% | 0.00% | – |
| Q4 2016 | $39,000 | -9.3% | 4,156 | -5.5% | 0.00% | – |
| Q3 2016 | $43,000 | -2.3% | 4,397 | -32.3% | 0.00% | – |
| Q2 2016 | $44,000 | +238.5% | 6,497 | +352.1% | 0.00% | – |
| Q1 2016 | $13,000 | -61.8% | 1,437 | -43.2% | 0.00% | – |
| Q4 2015 | $34,000 | +61.9% | 2,528 | +30.0% | 0.00% | – |
| Q3 2015 | $21,000 | +23.5% | 1,945 | +214.2% | 0.00% | – |
| Q2 2015 | $17,000 | +70.0% | 619 | +82.6% | 0.00% | – |
| Q1 2015 | $10,000 | -99.7% | 339 | -99.6% | 0.00% | -100.0% |
| Q4 2014 | $3,121,000 | -13.0% | 83,355 | -18.8% | 0.00% | -20.0% |
| Q3 2014 | $3,587,000 | -28.9% | 102,655 | -5.2% | 0.01% | -28.6% |
| Q2 2014 | $5,042,000 | +105.7% | 108,312 | +36.5% | 0.01% | +75.0% |
| Q1 2014 | $2,451,000 | +3985.0% | 79,346 | +2951.8% | 0.00% | – |
| Q4 2013 | $60,000 | – | 2,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |